Ipsen files an­oth­er Onivyde law­suit two weeks af­ter re­ceiv­ing new patent

Two weeks af­ter re­ceiv­ing a new patent on its pan­cre­at­ic can­cer treat­ment Onivyde, Ipsen has filed an­oth­er law­suit against a po­ten­tial com­peti­tor.

Ipsen ar­gued on …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER